Issue 33

What Happens When CDMO Partnerships Fail?

Why not sign up for our future email newsletters? Sign up here.

Included in this issue:

LEAD STORY

What Happens When Your CDMO Partnership Goes Wrong?

CDMO partnerships are great when they are successful, but what happens when they falter? The complexity of modern outsourcing partnerships means that failure is often costly, with consequences that can ripple across timelines, budgets, and reputations.

Read more here.

FEATURED STORIES

BioDuro Opens New Laboratory in Shanghai for Highly Potent Compound Synthesis

Read more here.

Bionova Appoints Bionique as Preferred Provider for Mycoplasma Testing

Read more here.

Bend Bioscience Expands Commercial Spray Drying and Granulation Capabilities

Read more here.

Esteve Química to Expand US Manufacturing Capabilities

Read more here.

Novo Nordisk Secures Exclusive Rights to Lexicon’s LX9851

Read more here.

Curium Acquires Monrol for Strategic Expansion in Nuclear Medicine

Read more here.

Delpharm Secures USD 42 Mn Investment to Upgrade Injectables Plant

Read more here.

Wheeler Bio Raises USD 35 Mn in Oversubscribed Series A Funding

Read more here.

Porton Advanced and Eureka Therapeutics Partner to Accelerate T-Cell Therapy Development

Read more here.

Suven Pharma Targets USD 1 Bn Revenue by 2030

Read more here.

SHL Medical and Kindeva Partner to Enhance Molly® Autoinjector Platform

Read more here.

TPN 33
Previous
Previous

Issue 34

Next
Next

Issue 32